Cargando…

Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion

Developments in High Throughput Screening aim at maximizing the number of samples per time and reducing the cost per sample, e.g., by applying very small sample volumes. The ultimate technological step in miniaturization is moving from microtiter plate wells to droplets, and from batch-wise characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Holtze, Christian, Weisse, Sebastian A., Vranceanu, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190191/
http://dx.doi.org/10.3390/mi8060193
_version_ 1783363515727216640
author Holtze, Christian
Weisse, Sebastian A.
Vranceanu, Marcel
author_facet Holtze, Christian
Weisse, Sebastian A.
Vranceanu, Marcel
author_sort Holtze, Christian
collection PubMed
description Developments in High Throughput Screening aim at maximizing the number of samples per time and reducing the cost per sample, e.g., by applying very small sample volumes. The ultimate technological step in miniaturization is moving from microtiter plate wells to droplets, and from batch-wise characterization to the continuous preparation and analysis of samples. A range of drop-based microfluidic screening platforms has emerged that benefit from drop-formation rates of thousands per second, perfect drop size uniformity, plug-flow and compartmentalization, and the possibility of continuously analyzing a train of drops. However, after many years of intensive research, only few commercial applications have been developed and substantial development in the field is still required to make them reliable and broadly applicable. Can academic research achieve this, given that most of the fundamental concepts have been described already, making it hard to publish a big story? Can start-up companies raise enough money to overcome the technical issues of drop-based screening platforms? This contribution addresses the question, focusing on how the different stakeholders in the field should interact so that disillusionment will not put a premature end to the development of drop-based screening technologies.
format Online
Article
Text
id pubmed-6190191
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61901912018-11-01 Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion Holtze, Christian Weisse, Sebastian A. Vranceanu, Marcel Micromachines (Basel) Opinion Developments in High Throughput Screening aim at maximizing the number of samples per time and reducing the cost per sample, e.g., by applying very small sample volumes. The ultimate technological step in miniaturization is moving from microtiter plate wells to droplets, and from batch-wise characterization to the continuous preparation and analysis of samples. A range of drop-based microfluidic screening platforms has emerged that benefit from drop-formation rates of thousands per second, perfect drop size uniformity, plug-flow and compartmentalization, and the possibility of continuously analyzing a train of drops. However, after many years of intensive research, only few commercial applications have been developed and substantial development in the field is still required to make them reliable and broadly applicable. Can academic research achieve this, given that most of the fundamental concepts have been described already, making it hard to publish a big story? Can start-up companies raise enough money to overcome the technical issues of drop-based screening platforms? This contribution addresses the question, focusing on how the different stakeholders in the field should interact so that disillusionment will not put a premature end to the development of drop-based screening technologies. MDPI 2017-06-20 /pmc/articles/PMC6190191/ http://dx.doi.org/10.3390/mi8060193 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Holtze, Christian
Weisse, Sebastian A.
Vranceanu, Marcel
Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title_full Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title_fullStr Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title_full_unstemmed Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title_short Commercial Value and Challenges of Drop-Based Microfluidic Screening Platforms–An Opinion
title_sort commercial value and challenges of drop-based microfluidic screening platforms–an opinion
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190191/
http://dx.doi.org/10.3390/mi8060193
work_keys_str_mv AT holtzechristian commercialvalueandchallengesofdropbasedmicrofluidicscreeningplatformsanopinion
AT weissesebastiana commercialvalueandchallengesofdropbasedmicrofluidicscreeningplatformsanopinion
AT vranceanumarcel commercialvalueandchallengesofdropbasedmicrofluidicscreeningplatformsanopinion